Market Cap | ₹1,470Cr |
ROE | 16.57% |
P/E Ratio(TTM) | 24.17 |
EPS(TTM) | 9.13 |
P/B Ratio | 6.14 |
Dividend Yield | 1.13% |
Industry P/E | 40.33 |
Book Value | 35.96 |
Debt to Equity | 0.04 |
Face Value | 2 |
Parent Organisation | Jagsonpal Pharmaceuticals Limited. |
Managing Director | Mr. Manish Gupta |
NSE Symbol | JAGSNPHARM |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Cohance Lifesciences | NA (0.00%) | 105.21 | ||
Emcure Pharmaceuticals | NA (0.00%) | 34.98 | ||
JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.27 | ||
Wockhardt | NA (0.00%) | -154.77 |